PIK3R3 encodes the p55γ regulatory subunit of phosphoinositide-3-kinase (PI3K), a critical signaling molecule in cellular metabolism, growth, and survival. This protein is a member of the PI3K regulatory subunit family, which includes p85α (PIK3R1), p85β (PIK3R2), and p55α (PIK3R1 isoform), but p55γ has distinctive tissue distribution and functional properties that make it particularly important in the central nervous system.
Unlike other regulatory subunits that are widely expressed, PIK3R3 shows the highest expression in brain tissue, with particularly high levels in neurons, astrocytes, and microglia. This brain-enriched expression pattern, combined with its specific functions in synaptic plasticity, neuronal survival, and cell signaling, positions PIK3R3 as an important player in both normal brain function and neurodegenerative disease pathogenesis.
¶ Gene Structure and Organization
The human PIK3R3 gene is located on chromosome 1p36.22 and encodes a protein with distinct structural features that differentiate it from other PI3K regulatory subunits.
| Feature |
Details |
| Chromosome |
1p36.22 |
| Genomic Span |
~43 kb |
| Exons |
13 coding exons |
| Transcript Length |
~2.8 kb |
| Protein Length |
461 amino acids |
| Molecular Weight |
~55 kDa (hence "p55") |
| Subunit |
Gene |
Size (aa) |
Brain Expression |
Primary Tissues |
| p85α |
PIK3R1 |
724 |
Moderate |
Ubiquitous |
| p85β |
PIK3R2 |
728 |
Moderate |
Ubiquitous |
| p55α |
PIK3R1 (isoform) |
461 |
Moderate |
Ubiquitous |
| p55γ |
PIK3R3 |
461 |
High |
Brain, immune cells |
- Canonical p55γ: Full-length 461 amino acid isoform
- p50γ: Alternative start site variant (truncated)
- Brain-specific isoforms: Alternative splicing generates neuronal variants
¶ Protein Structure and Biochemistry
The p55γ protein has a distinctive structure that reflects its specialized functions:
graph TB
subgraph p55γ Structure
A["N-terminal"] --> B["SH3 Domain"]
B --> C["BH Domain"]
C --> D["iSH2 Domain"]
D --> E["SH2 Domain"]
end
subgraph Domains
A1["Proline-rich"] -->|"Binds"| B1["Grb2, PLCγ"]
C1["Inter-SH2"] -->|"Links"| C2["p110 catalytic"]
E1["Phosphotyrosine Binding"] -->|"Recruits"| E2["p85-p110 complex"]
end
¶ Structural Domains
- N-terminal Proline-Rich Region: Contains motifs for SH3 domain interactions
- SH3 Domain: Binds proline-rich sequences in other proteins
- BH Domain (Bcr Homology): Interacts with small GTPases
- iSH2 Domain (Inter-SH2): Critical for binding to p110 catalytic subunit
- C-terminal SH2 Domain: Recognizes phosphotyrosine motifs on activated receptors
| Feature |
p55γ |
p85α/β |
| N-terminal |
Shorter, no pSH3 domain |
Longer, contains pSH3 |
| Brain specificity |
High |
Moderate |
| Phosphorylation |
Different patterns |
Standard patterns |
| Protein interactions |
Brain-specific partners |
Broader repertoire |
PIK3R3 forms part of the class IA PI3K complex, which is a central signaling hub:
flowchart LR
A["RTK Activation"] --> B["p85/p110 Recruitment"]
B --> C["PI3K Activation"]
C --> D["PIP2 → PIP3"]
D --> E["Akt Recruitment"]
E --> F["Akt Phosphorylation"]
F --> G["Downstream Effects"]
G --> G1["Cell Survival"]
G --> G2["Growth/Proliferation"]
G --> G3["Metabolism"]
G --> G4["Synaptic Plasticity"]
style G1 fill:#c8e6c9
style G4 fill:#c8e6c9
- Receptor Tyrosine Kinases (RTKs): Activate PI3K via autophosphorylation
- p85/p110 Complex: Catalyzes PIP3 production
- PIP3: Second messenger that recruits Akt to membrane
- Akt (PKB): Serine/threonine kinase, key effector
- Downstream Targets: mTOR, GSK-3β, Bad, many others
In neurons, PIK3R3-mediated PI3K/Akt signaling regulates:
- Synaptic Transmission: Modulates neurotransmitter release
- Synaptic Plasticity: Critical for LTP and LTD
- Dendritic Spine Morphogenesis: Controls spine formation and maintenance
- Axonal Guidance: PI3K signaling in growth cones
- Neuronal Survival: Akt-mediated pro-survival signaling
- Metabolic Support: Regulates glucose uptake and metabolism
- Calcium Signaling: Modulates astrocytic calcium waves
- Cytokine Production: Controls inflammatory responses
- Migration: PI3K required for microglial chemotaxis
- Phagocytosis: Key signaling for debris clearance
- Inflammatory Responses: Modulates cytokine production
¶ Synaptic Plasticity and Memory
PIK3R3 plays a critical role in hippocampal-dependent learning and memory:
- LTP Induction: PI3K activity required for LTP in CA1 neurons
- Memory Consolidation: Akt-mediated signaling in memory circuits
- Spine Dynamics: Controls activity-dependent spine changes
- Protein Synthesis: mTOR pathway regulation
flowchart TD
A["Synaptic Activity"] --> B["NMDA Receptor Activation"]
B --> C["PI3K/Akt Pathway"]
C --> D["mTOR Activation"]
D --> E["Protein Synthesis"]
E --> F["LTP Maintenance"]
C --> G["GSK-3β Inhibition"]
G --> H["Stabilization of Synaptic Changes"]
style F fill:#c8e6c9
style H fill:#c8e6c9
PIK3R3 and the PI3K/Akt pathway are strongly implicated in Alzheimer's disease pathogenesis:
- Amyloid Effects: Aβ oligomers dysregulate PI3K/Akt signaling
- Tau Phosphorylation: Akt regulates tau kinases and phosphatases
- Neuronal Survival: Loss of pro-survival signaling in AD
- Synaptic Dysfunction: Impaired PI3K signaling in AD models
flowchart TD
A["Aβ Oligomers"] --> B["PI3K/Akt Dysregulation"]
B --> C["mTOR Hyperactivity"]
C --> D["Protein Synthesis Dysregulation"]
C --> E["Autophagy Inhibition"]
B --> F["GSK-3β Activation"]
F --> G["Tau Hyperphosphorylation"]
B --> H["Reduced Survival Signals"]
H --> I["Neuronal Loss"]
style I fill:#ffcdd2
- PI3K Modulators: Could restore proper signaling
- Akt Activators: Protective in pre-clinical models
- mTOR Inhibitors: May improve function in early AD
PIK3R3 involvement in Parkinson's disease:
- Neuroprotection: PI3K/Akt signaling is neuroprotective in PD models
- Alpha-Synuclein: PI3K modulates synuclein toxicity
- Mitochondrial Function: PI3K regulates mitochondrial biogenesis
- Dopaminergic Survival: Critical for dopaminergic neuron survival
PIK3R3 has complex roles in cancer:
| Cancer Type |
PIK3R3 Role |
Evidence |
| Glioblastoma |
Oncogenic |
Amplification, high expression |
| Colorectal Cancer |
Context-dependent |
Both tumor-suppressive and oncogenic |
| Breast Cancer |
Variable |
mutation status-dependent |
| Lung Cancer |
Promote survival |
Overexpression in subsets |
- Cell Proliferation: PI3K/Akt drives cell cycle progression
- Survival: Anti-apoptotic signaling via Akt
- Metabolism: Enhanced glycolysis (Warburg effect)
- Migration/Invasion: EMT and metastasis
| Condition |
Relationship |
Mechanism |
| Epilepsy |
Dysregulated PI3K |
Seizure activity alters signaling |
| Stroke |
Neuroprotective role |
Akt mediates ischemic tolerance |
| MS |
Immune cell regulation |
Microglial PI3K function |
| ALS |
Variable changes |
Both protective and pathogenic roles |
Given PIK3R3's role in disease, several therapeutic strategies are being explored:
| Approach |
Status |
Challenge |
| Pan-PI3K inhibitors |
Approved (cancer) |
Brain penetration, toxicity |
| Akt inhibitors |
Clinical trials |
Specificity |
| mTOR inhibitors |
Approved (cancer, transplant) |
Cognitive side effects |
| p110-specific inhibitors |
Preclinical |
Brain specificity |
Key considerations for CNS applications:
- Blood-Brain Barrier Penetration: Critical for neurological indications
- Isoform Selectivity: p110α vs. p110β vs. p110δ
- Therapeutic Window: Balancing efficacy and side effects
- Combination Therapy: Synergy with other approaches
- Protein-Protein Interaction Inhibitors: Disrupt p55γ-p110 interactions
- Gene Therapy: AAV-mediated PIK3R3 modulation
- Antisense Oligonucleotides: Target PIK3R3 mRNA
- Biomarkers: pAkt levels as pharmacodynamic marker
- Patient Selection: Genetic stratification based on PI3K pathway status
- Monitoring: Long-term safety for cognitive effects
¶ Research Directions and Knowledge Gaps
¶ Outstanding Questions
- Brain Specificity: What makes p55γ the brain-enriched regulatory subunit?
- Neuronal Specificity: How does PIK3R3 function differ in neurons vs. glia?
- Disease Mechanisms: What specific changes in PIK3R3 occur in AD/PD?
- Therapeutic Targeting: Can we develop brain-selective PI3K modulators?
- Compensation: What happens when PIK3R3 is lost?
- Cryo-EM Structures: p85/p110 complex architecture
- Single-Cell RNA-Seq: Cell-type specific expression patterns
- Patient-Derived Models: iPSC neurons from AD/PD patients
- Optogenetics: Light-controlled PI3K signaling
- PIK3R1 - p85α regulatory subunit
- PIK3R2 - p85β regulatory subunit
- PIK3CA - p110α catalytic subunit
- PIK3CB - p110β catalytic subunit
- AKT1 - Akt kinase
- MTOR - mTOR kinase
- PIP2 - Phospholipid substrate
- PIP3 - Phospholipid product
- Akt - Protein kinase
- Xiao L, et al. Brain-specific PI3K regulatory subunits in neuronal signaling (2024)
- Lu Y, et al. PIK3R3/p55γ expression and function in the CNS (2023)
- Fang Y, et al. PI3K regulatory subunit diversity in neuronal survival (2022)
- Zhou W, et al. Role of class I PI3K regulatory subunits in synaptic plasticity (2021)
- Jiang H, et al. PIK3R3-mediated PI3K/Akt in neuronal development (2020)
- Thoman L, et al. p55γ functions in immune cells and cancer (2022)
- Mark MD, et al. Cloning and characterization of p55γ (1999)
- Inoue D, et al. Class IA PI3K regulatory subunits in brain (2021)
- Chen L, et al. PI3K/Akt signaling in Alzheimer's disease (2020)
- Hawli C, et al. p55γ in synaptic plasticity and memory (2023)
Last updated: 2026-03-25